Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rapt Therapeutics
Biotech
Rapt faces clinical hold after liver failure in immunology trial
Rapt is reeling from an “unfortunate and unexpected” clinical hold after a patient in a phase 2 immunology trial experienced liver failure.
Max Bayer
Feb 20, 2024 10:42am
Exscientia fires CEO—Chutes & Ladders
Feb 16, 2024 9:30am
Moderna promotes Andres to new strategy role—Chutes & Ladders
Sep 30, 2022 9:30am
Rapt edges into Asia with Hanmi I-O deal worth up to $118M
Dec 3, 2019 4:05pm
Rapt Therapeutics revives IPO, files to raise $75M
Oct 23, 2019 7:10am
